Flavio G. Rocha

机构：Oregon Health & Science University · ORCID：0000-0002-6257-5796

发表论文 243 篇 · 总被引 4674 次 · h-index 35

代表论文

• NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma (2023 · Annals of Surgical Oncology · 被引 83)
• Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 76)
• Updated Management of Colorectal Cancer Liver Metastases: Scientific Advances Driving Modern Therapeutic Innovations (2023 · Cellular and Molecular Gastroenterology and Hepatology · 被引 49)
• The multidisciplinary management of cholangiocarcinoma (2022 · Cancer · 被引 30)
• Socioeconomic and Geographic Disparities in the Referral and Treatment of Pancreatic Cancer at High-Volume Centers (2022 · JAMA Surgery · 被引 27)
• Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy (2023 · Cells · 被引 20)